JAMP Valproic Acid Oral Solution: Presence of large solid crystals in affected lots
Brand(s)
Last updated
Summary
Product
JAMP Valproic Acid Oral Solution
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution
National
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot numbers |
|---|---|---|---|---|---|
JAMP Valproic Acid |
Valproic Acid oral solution |
DIN 02532441 |
Solution |
VALPROIC ACID (SODIUM VALPROATE) 250mg/ 5mL |
231597, 231599 & 231601 |
Issue
Presence of large solid crystals in affected lots
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Related recalls and alerts
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
JAMP Pharma Corporation 1310 Rue Nobel, Boucherville,QC, J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Identification number
RA-77319
Get notified
Receive emails about new and updated recall and safety alerts.